BBNA
ABBV icon

Bremer Bank National Association’s AbbVie ABBV Stock Holding History

Bremer Bank National Association’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$670K Sell
3,200
-57
-2% -$11.1K 0.12% 94
2024
Q4 		$579K Sell
3,257
-30
-0.9% -$5.52K 0.11% 97
2024
Q3 		$649K Sell
3,287
-477
-13% -$89K 0.12% 98
2024
Q2 		$646K Sell
3,764
-155
-4% -$25.7K 0.13% 103
2024
Q1 		$714K Sell
3,919
-5,976
-60% -$1.03M 0.13% 104
2023
Q4 		$1.53M Sell
9,895
-64
-0.6% -$9.33K 0.29% 79
2023
Q3 		$1.48M Sell
9,959
-304
-3% -$44.6K 0.29% 79
2023
Q2 		$1.38M Sell
10,263
-266
-3% -$39K 0.26% 89
2023
Q1 		$1.68M Sell
10,529
-614
-6% -$93.9K 0.32% 76
2022
Q4 		$1.8M Buy
11,143
+5,896
+112% +$904K 0.35% 74
2022
Q3 		$705K Sell
5,247
-314
-6% -$45.1K 0.16% 105
2022
Q2 		$852K Sell
5,561
-260
-4% -$39.7K 0.16% 105
2022
Q1 		$944K Sell
5,821
-822
-12% -$119K 0.16% 108
2021
Q4 		$899K Buy
6,643
+13
+0.2% +$1.54K 0.15% 116
2021
Q3 		$715K Buy
6,630
+86
+1% +$9.83K 0.14% 109
2021
Q2 		$737K Sell
6,544
-242
-4% -$27.3K 0.16% 110
2021
Q1 		$735K Sell
6,786
-466
-6% -$49.8K 0.17% 110
2020
Q4 		$777K Sell
7,252
-285
-4% -$27.4K 0.19% 102
2020
Q3 		$660K Sell
7,537
-2,857
-27% -$269K 0.17% 106
2020
Q2 		$1.02M Sell
10,394
-176
-2% -$15.5K 0.29% 91
2020
Q1 		$805K Sell
10,570
-79
-0.7% -$6.73K 0.23% 103
2019
Q4 		$943K Buy
10,649
+3,133
+42% +$260K 0.2% 110
2019
Q3 		$569K Sell
7,516
-1,634
-18% -$112K 0.13% 138
2019
Q2 		$666K Sell
9,150
-2,617
-22% -$206K 0.14% 137
2019
Q1 		$934K Buy
+11,767
New +$963K 0.18% 120

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bremer Bank National Association's ABBV Position: Q1 2025 in Review

Bremer Bank National Association reduced its AbbVie (ABBV) stake by 1.8% in Q1 2025, selling an estimated $11.1K and leaving 3,200 shares worth $670K. The position accounts for 0.12% of the portfolio, ranked #94.

Bremer Bank National Association first reported a position in ABBV in Q1 2019 and has held it in 25 quarters since. The position peaked at $1.8M in Q4 2022. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Bremer Bank National Association held 3,200 shares of AbbVie worth $670K as of Q1 2025.
  • Bremer Bank National Association sold 57 AbbVie shares in Q1 2025, an estimated $11.1K.
  • AbbVie made up 0.12% of Bremer Bank National Association's portfolio in Q1 2025, its #94 holding.
  • Bremer Bank National Association first reported a position in AbbVie in Q1 2019 and has held it in 25 quarters since.
  • Bremer Bank National Association's AbbVie position peaked at $1.8M in Q4 2022.
  • 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Bremer Bank National Association's 13F filing for Q1 2025, filed 10 Apr 2025.